Reviva Pharmaceuticals Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 5
Employees
  • Stock Symbol
  • RVPH
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $4.23
  • (As of Wednesday Closing)

Reviva Pharmaceuticals General Information

Description

Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system, respiratory, and metabolic diseases. The company is currently focused on the development of its lead product candidate, RP5063, which targets schizophrenia, bipolar disorder, major depressive disorder, behavioral & psychotic symptoms, dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, and also respiratory indications such as pulmonary arterial hypertension & idiopathic pulmonary fibrosis.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 19925 Stevens Creek Boulevard
  • Suite 100
  • Cupertino, CA 95014
  • United States
+1 (408) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Reviva Pharmaceuticals Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.23 $4.28 $3.29 - $9.61 $57.3M 13.4M 124K -$0.89

Reviva Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Nov-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 80,732
Revenue 0 0 0
EBITDA (2,434) (376) (1,121)
Net Income (3,783) (847) (1,680)
Total Assets 34,694 8,762 3 122
Total Debt 1,975 0 3,765 4,865
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Reviva Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Reviva Pharmaceuticals‘s full profile, request access.

Request a free trial

Reviva Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company. It is developing a portfolio of inter
Drug Discovery
Cupertino, CA
5 As of 2020
0000
00000000 0000

00000 00

empor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitatio
0000 000000000
Washington, DC
000 As of 0000
00000
000000&0

000000 0

inim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000 000000000
Boston, MA
00 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Reviva Pharmaceuticals Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Vanda Pharmaceuticals Formerly VC-backed Washington, DC 000 00000 000000&0
000000 00000000000 Formerly VC-backed Boston, MA 00 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Lexington, MA 00 00000 000000000 00000
00000000 Formerly VC-backed Dublin, Ireland 0000 00.000 000000000 00.000
To view Reviva Pharmaceuticals’s complete competitors history, request access »

Reviva Pharmaceuticals Executive Team (4)

Name Title Board Seat Contact Info
Laxminarayan Bhat Ph.D Chief Executive Officer & Board Member
Narayan Prabhu Chief Financial Officer, Finance
Marc Cantillon MD Chief Medical Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Reviva Pharmaceuticals Board Members (8)

Name Representing Role Since
Bradley Thompson Ph.D Reviva Pharmaceuticals Board Member 000 0000
Laxminarayan Bhat Ph.D Reviva Pharmaceuticals Chief Executive Officer & Board Member 000 0000
Les Funtleyder Self Board Member 000 0000
Parag Saxena Self Chairman & Board Member 000 0000
Peder Jensen MD Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Reviva Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reviva Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 14-Dec-2020 000000000000000000 Special Purpose Acquisition Company (SPAC) 000000000000 0000 00.0
To view Reviva Pharmaceuticals’s complete acquisitions history, request access »